Teladoc Soars 11% on Q3 Beat and Raised Outlook as “Insurance Revenue Exceeded Our Expectations”
Teladoc Health (TDOC) shares rose 11% after Q3 results beat adjusted EBITDA guidance, increasing 14% to $79.4M. BetterHelp's insurance revenue grew to $32.1M, offsetting some cash-pay losses. The company raised its 2026 revenue and EBITDA outlook. Revenue fell 3% to $605.1M, marking the third consecutive quarterly decline.
How this was made
The 30-second read
Why it matters
The earnings beat and guidance raise triggered an 11% share price jump, indicating strong short‑term buying pressure.
Market read
Teladoc's earnings beat and raised outlook provide a clear catalyst for immediate trading decisions.
What to watch
Nearly $1 bn of convertible notes maturing within a year could pressure cash flow if earnings falter.
Background
Teladoc Health (TDOC) posted Q3 results with revenue down 3% but adjusted EBITDA up 14%, and lifted the low end of its 2026 outlook.
Ticker impact
Teladoc Health reported Q3 adjusted EBITDA beat and raised its 2026 guidance, driving an 11% stock surge.
upward as market prices in the earnings beat and raised guidance
The fresh beat and guidance raise are primary disclosures that moved the stock 11% intraday.
Market effects
Telehealth sector may see renewed investor interest as Teladoc demonstrates profitability growth.
U.S. market sentiment for digital health stocks improves.
Limited to investors tracking U.S. telehealth and broader tech earnings trends.
Counterpoint
Higher guidance may be unsustainable if insurance revenue growth stalls, risking future downside.
Key entities
- companyTeladoc Health
Provider of virtual healthcare services.
- divisionBetterHelp
Teladoc's consumer mental‑health platform.
